- Home
- MCRB vs XOS Comparison
MCRB vs XOS Comparison
Compare MCRB & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | XOS |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 37.2M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCRB | XOS |
|---|---|---|
| Price | $4.04 | $2.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | $7.00 |
| AVG Volume (30 Days) | 50.0K | ★ 389.6K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.49 |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $45,992,000.00 |
| Revenue This Year | N/A | $29.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.00 | $1.60 |
| 52 Week High | $29.98 | $8.27 |
Technical Indicators
Market Signals| Indicator | MCRB | XOS |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 44.61 |
| Support Level | N/A | $2.02 |
| Resistance Level | $5.80 | $3.07 |
| Average True Range (ATR) | 0.37 | 0.15 |
| MACD | -0.13 | -0.07 |
| Stochastic Oscillator | 7.32 | 18.89 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.